59 completed, 21 recruiting, 13 unknown, 7 terminated. 30 Phase 2, 16 Phase 3, 14 Not applicable, 11 Phase 1, 7 Phase 4.
Follow Granuloma: new trials by email Literature Review of Granuloma trials Research Report on Granuloma
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Prospective Stage-Stratified Histopathologic Study and Proposed Disease-Evolution Model of Gluteal Permanent Synthetic Filler Complications Standardized Tissue Sampling During Clinically Indicated Surgery, Blinded Histopathologic Scoring - Foreign-Body Reaction, Granulomatous Disease | Not yet recruiting | Research Inc | 200 | 2026-10-01 | 2026-09-09 | |
| The GranStone Trial empagliflozin (Jardiance) 25 mg, Losartan 100 mg - Paraffinoma, Granuloma, Foreign-Body | Phase 2 / Phase 3 | Not yet recruiting | Martin Blomberg Jensen | 100 | 2026-09-01 | 2026-09-18 |
| Ex Vivo Thermal Damage Assessment During Electrocautery Cutting of Explanted Biopolymer-Infiltrated Tissue Thermal Injury Response, Soft Tissue Disease | Not yet recruiting | Research Inc | 50 | 2026-08-16 | 2026-08-14 | |
| Roll-over Study for Participants Who Have Completed a Previous Clinical Study With Benralizumab (Fasenra) and Benefit From Continued Treatment Benralizumab - Asthma, Eosinophilic Granulomatosis With Polyangiitis (EGPA) | Phase 3 | Recruiting | AstraZeneca | 230 | 2026-07-24 | 2026-10-27 |
| Benralizumab Effectiveness in EGPA Benralizumab 30 mg/ml - Eosinophilic Granulomatosis With Polyangiitis (EGPA) | Recruiting | European EGPA Study Group | 100 | 2026-02-11 | 2026-09-11 | |
| Lymphocyte Subpopulations in Peripheral Giant Cell Granuloma Immunohistochemical Analysis - Peripheral Giant Cell Granuloma, Gingival Lesions | Completed | Ataturk University | 28 | 2026-01-01 | 2026-05-18 | |
| Does the Thickness of the Gastrostomy Affect the Incidence of Complications? A Prospective Randomized Single-Center Study in Children 12 Fr gastrostomy tube/button, 14 Fr gastrostomy tube/button - Gastrostomy Complications, Gastrostomy Size | Not applicable | Recruiting | Therese Hössjer | 200 | 2025-11-20 | 2025-12-24 |
| Beyond EOsinophils: proteoMICS to Identify Potential Biomarker of Organ Damage and Response to MEPOLIZUMAB in EGPA Mepolizumab 100 MG Injection [Nucala], Mepolizumab 300 mg - EGPA - Eosinophilic Granulomatosis With Polyangiitis, Severe Asthma | Phase 4 | Enrolling by invitation | Azienda Ospedaliero Universitaria di Cagliari | 90 | 2025-10-17 | 2026-01-15 |
| Long-Term Safety and Effectiveness of Mepolizumab 300 mg in Europe (Mepo LTF Study) Mepolizumab 300 mg - Eosinophilic Granulomatosis With Polyangiitis (Churg-Strauss) (EGPA) | Completed | European EGPA Study Group | 299 | 2025-09-18 | 2026-10-27 | |
| Effectiveness on Sino-Nasal Symptoms Of Mepolizumab 300 Mepolizumab 300 mg - Sinus Disease, EGPA - Eosinophilic Granulomatosis With Polyangiitis | Completed | Fondazione Policlinico Universitario Agostino Gemelli IRCCS | 52 | 2025-09-12 | 2026-05-18 | |
| The Use of Machine Learning Techniques for the Differential Diagnosis Between Eosinophilic Granulomatosis With Polyangiitis and Hypereosinophilic Syndrome Blood draw for the laboratory assessment - EGPA - Eosinophilic Granulomatosis With Polyangiitis, HES - Hypereosinophilic Syndrome | Not applicable | Recruiting | Fondazione IRCCS Policlinico San Matteo di Pavia | 60 | 2025-06-01 | 2025-12-10 |
| A Trial to Investigate Benralizumab in Children With Eosinophilic Diseases Benralizumab - Eosinophilic Granulomatosis With Polyangiitis (EGPA), Hypereosinophilia Syndrome (HES) | Phase 3 | Recruiting | AstraZeneca | 14 | 2025-04-17 | 2026-10-28 |
| Eosinophil Subpopulations in Eosinophilic-associated Diseases Eosinophilic Asthma, Eosinophilic Granulomatosis With Polyangiitis (EGPA) | Not yet recruiting | University of Florence | 160 | 2025-04-01 | 2025-04-04 | |
| Tyrosine Kinase 2 (TYK2) for GA and CS Deucravacitinib - Sarcoidosis, Granuloma Annulare | Phase 2 | Withdrawn | Yale University | 2025-03-01 | 2025-04-29 | |
| Effect of Laser and Sclerotic Agent in the Treatment of Oral Granuloma laser therapy, Sclerotherapy - Pyogenic Granuloma of Gingiva | Not applicable | Not yet recruiting | Assiut University | 20 | 2024-10-15 | 2024-10-15 |
| Retrospective Analysis of Systemic Glucocorticoid Mediated Long-term Effects, Patient Pathways and Economic Burden Across Multiple Indications Asthma | Completed | GlaxoSmithKline | 107032 | 2024-07-01 | 2026-06-01 | |
| Using Artificial Intelligence to Help Doctors Identify Different Skin Conditions and Improve Patient Care AI-based medical device for aided diagnosis in Dermatology - Dermatitis, Melanoma (Skin Cancer) | Completed | AI Labs Group S.L | 16 | 2024-06-01 | 2026-02-24 | |
| Explore the Efficacy and Mechanism of Action of Tezepelumab in Eosinophilic Granulomatosis With Polyangiitis Tezepelumab, Placebo - EGPA - Eosinophilic Granulomatosis With Polyangiitis | Phase 2 | Active not recruiting | Imperial College London | 42 | 2024-05-15 | 2026-04-29 |
| The Epigenomic Signature of Eosinophilic Granulomatosis With Polyangiitis Eosinophilic Granulomatosis With Polyangiitis | Unknown | Meyer Children's Hospital IRCCS | 300 | 2024-04-01 | 2024-02-23 | |
| Ocular Manifestations of Granulomatosis With Polyangiitis. Optical coherence tomography angiography - GPA, Vasculitis | Recruiting | Military Institute od Medicine National Research Institute | 70 | 2024-03-01 | 2026-06-24 |
Showing 20 of 116. Sign in to see all of them.
Churg-Strauss Syndrome (61) · Granulomatosis with Polyangiitis (26) · Microscopic Polyangiitis (26) · Vasculitis (18) · Polyarteritis Nodosa (16) · Takayasu Arteritis (12) · Anti-Neutrophil Cytoplasmic Antibody-Associated Vasculitis (10) · Giant Cell Arteritis (10) · Granuloma Annulare (10) · Granuloma, Plasma Cell (10) · IgA Vasculitis (8) · Granuloma, Foreign-Body (7) · Lymphoma, Large-Cell, Anaplastic (7) · Behcet Syndrome (6)
Hemic and Lymphatic Diseases (92) · Lymphatic Diseases (92) · Lymphoproliferative Disorders (88) · Immune System Diseases (80) · Skin and Connective Tissue Diseases (79) · Skin Diseases (77) · Cardiovascular Diseases (63) · Pathologic Processes (63) · Pathological Conditions, Signs and Symptoms (63) · Vascular Diseases (63) · Autoimmune Diseases (62) · Skin Diseases, Vascular (62) · Systemic Vasculitis (58) · Anti-Neutrophil Cytoplasmic Antibody-Associated Vasculitis (52)
mepolizumab (13) · Cyclophosphamide (7) · Azathioprine (5) · Crizotinib (4) · Rituximab (4) · benralizumab (4) · Blood Specimen Collection (3) · Prednisone (3) · ceritinib (3) · Adrenal Cortex Hormones (2) · Methotrexate (2) · Methylprednisolone (2) · Surgical Procedures, Operative (2) · Abatacept (1) · Antilymphocyte Serum (1)
Assistance Publique - Hôpitaux de Paris (7) · University of Pennsylvania (7) · GlaxoSmithKline (6) · AstraZeneca (4) · Novartis Pharmaceuticals (4) · University of South Florida (4) · Hospital Angeles del Pedregal (3) · Research Inc (3) · Charite University, Berlin, Germany (2) · European EGPA Study Group (2) · Fondazione Policlinico Universitario Agostino Gemelli IRCCS (2) · Imperial College London (2) · Martin Blomberg Jensen (2) · National Institute of Allergy and Infectious Diseases (NIAID) (2) · National Institutes of Health Clinical Center (CC) (2)
United States (48) · France (23) · Italy (23) · United Kingdom (21) · Canada (19) · Germany (17) · Netherlands (12) · Japan (10) · Spain (10) · South Korea (8) · Denmark (7) · Poland (7) · Belgium (6) · Turkey (Türkiye) (6) · Austria (5)
Peter A Merkel, MD, MPH (5) · Peter A. Merkel, MD, MPH (4) · Amanda M. Terry, MA (3) · Megan Clowse, MD, MPH (2) · Michael Wechsler, MD (2) · Peter C. Grayson, MD (2) · Peter Merkel, MD, MPH (2) · AJ Gelderblom, Prof (1) · Aaron R Weiss (1) · Adrian Schreiber, PD Dr. med. (1) · Ahmed Mortada Fikry, professor (1) · Alan Salama (1) · Anoop J Chauhan, PhD FRCP (1) · Antoine Sreih, MD (1)
PMID 28514601, PMID 31719529, PMID 33001543, PMID 34347947, PMID 35612893, PMID 35850947, PMID 37161084, PMID 38251561, PMID 38393328, PMID 18240234, PMID 21325353, PMID 2202307, PMID 23590801, PMID 25153486, PMID 25693055, PMID 27461586, PMID 27940595, PMID 28678392, PMID 28950372, PMID 29016646, PMID 29216400, PMID 29567632, PMID 29669701, PMID 30697903, PMID 31056661, PMID 32638567, PMID 32702309, PMID 32827353, PMID 33011303, PMID 33065367, PMID 33164993, PMID 33317858, PMID 33718405, PMID 33760691, PMID 34392187, PMID 34515544, PMID 34780709, PMID 34814185, PMID 35106968, PMID 35668129, PMID 36356657, PMID 36874269, PMID 36927642, PMID 37024906, PMID 37334358, PMID 37449658, PMID 37457743, PMID 37523624, PMID 37550002, PMID 37854715
2023 (4), U54AR057319 (3), 2016 (2), 2014 (1), 2018 (1), 2019 (1), 2025 (1), U10CA098543 (1), U10CA180830 (1), U10CA180886 (1), UL1RR024150 (1)